Telomeres and disease: Enter TERRA

RNA Biology

Volumn 9, Issue 6, 2012, Pages 843-849

  Maicher, André ^a   Kastner, Lisa ^a   Luke, Brian ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Genomic instability; Non coding RNA; Telome syndrome; Telomere; TERRA

Indexed keywords

DNA METHYLTRANSFERASE 1; DYSKERIN; NHP2 PROTEIN; NOP10 PROTEIN; NUCLEAR PROTEIN; RNA POLYMERASE II; TCAB1 PROTEIN; TELOMERASE REVERSE TRANSCRIPTASE; TELOMERE BINDING PROTEIN; TELOMERIC REPEAT CONTAINING RNA; TIN2 PROTEIN; UNCLASSIFIED DRUG; UNTRANSLATED RNA;

APLASTIC ANEMIA; BIOGENESIS; CANCER CELL; CARCINOGENESIS; CELL AGING; DNA MODIFICATION; DYSKERATOSIS CONGENITA; FIBROSING ALVEOLITIS; GENE CONTROL; GENE INSERTION; GENE MUTATION; GENE REPRESSION; GENETIC DISORDER; HETEROCHROMATIN; HISTONE MODIFICATION; IMMUNODEFICIENCY CENTROMERIC REGION INSTABILITY FACIAL ANOMALY; LIVER CIRRHOSIS; NEOPLASM; PATHOPHYSIOLOGY; REPORTER GENE; REVIEW; TELOMERE SHORTENING; TISSUE DEGENERATION;

EID: 84863479873     PISSN: 15476286     EISSN: 15558584     Source Type: Journal    
DOI: 10.4161/rna.20330     Document Type: Review

References (72)

1. Giraud-Panis MJ, Teixeira MT, Géli V, Gilson E. CST meets shelterin to keep telomeres in check. Mol Cell 2010; 39:665-76; PMID:20832719; http://dx.doi.org/10.1016/j.molcel.2010.08.024.
2. de Lange T. How telomeres solve the end-protection problem. Science 2009; 326:948-52; PMID:19965504; http://dx.doi.org/10.1126/science.1170633.
3. Palm W, de Lange T. How shelterin protects mammalian telomeres. Annu Rev Genet 2008; 42:301-34; PMID:18680434; http://dx.doi.org/10.1146/annurev.genet. 41.110306.130350.
4. de Lange T. Shelterin: the protein complex that shapes and safeguards human telomeres. Genes Dev 2005; 19:2100-10; PMID:16166375; http://dx.doi.org/ 10.1101/gad.1346005.
5. Denchi EL, de Lange T. Protection of telomeres through independent control of ATM and ATR by TRF2 and POT1. Nature 2007; 448:1068-71; PMID:17687332; http://dx.doi.org/10.1038/nature06065.
6. Karlseder J, Smogorzewska A, de Lange T. Senescence induced by altered telomere state, not telomere loss. Science 2002; 295:2446-9; PMID:11923537; http://dx.doi.org/10.1126/science.1069523.
7. Murnane JP. Telomere dysfunction and chromosome instability. Mutat Res 2012; 730:28-36; PMID:21575645; http://dx.doi.org/10.1016/j.mrfmmm.2011.04.008.
8. Lingner J, Cooper JP, Cech TR. Telomerase and DNA end replication: no longer a lagging strand problem? Science 1995; 269:1533-4; PMID:7545310; http://dx.doi.org/10.1126/science.7545310.
9. Hug N, Lingner J. Telomere length homeostasis. Chromosoma 2006; 115:413-25; PMID:16741708; http://dx.doi.org/10.1007/s00412-006-0067-3.
10. Harley CB, Futcher AB, Greider CW. Telomeres shorten during ageing of human fibroblasts. Nature 1990; 345:458-60; PMID:2342578; http://dx.doi.org/10. 1038/345458a0.
11. O'Sullivan RJ, Karlseder J. Telomeres: protecting chromosomes against genome instability. Nat Rev Mol Cell Biol 2010; 11:171-81; PMID:20125188.
12. Artandi SE, DePinho RA. Telomeres and telomerase in cancer. Carcinogenesis 2010; 31:9-18; PMID:19887512; http://dx.doi.org/10.1093/carcin/ bgp268.
13. Shay JW, Wright WE. Role of telomeres and telomerase in cancer. Semin Cancer Biol 2011; 21:349-53; PMID:22015685; http://dx.doi.org/10.1016/j. semcancer.2011.10.001.
14. Davoli T, Denchi EL, de Lange T. Persistent telomere damage induces bypass of mitosis and tetraploidy. Cell 2010; 141:81-93; PMID:20371347; http://dx.doi.org/10.1016/j.cell.2010.01.031.
15. Bodnar AG, Ouellette M, Frolkis M, Holt SE, Chiu CP, Morin GB, et al. Extension of life-span by introduction of telomerase into normal human cells. Science 1998; 279:349-52; PMID:9454332; http://dx.doi.org/10.1126/science.279. 5349.349.
16. Greider CW. Telomeres, telomerase and senescence. Bioessays 1990; 12:363-9; PMID:2241933; http://dx.doi.org/10.1002/bies.950120803.
17. Shay JW, Wright WE. Senescence and immortalization: role of telomeres and telomerase. Carcinogenesis 2005; 26:867-74; PMID:15471900; http://dx.doi.org/ 10.1093/carcin/bgh296.
18. Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PL, et al. Specific association of human telomerase activity with immortal cells and cancer. Science 1994; 266:2011-5; PMID:7605428; http://dx.doi.org/10.1126/ science.7605428.
19. Armanios M. Syndromes of telomere shortening. Annu Rev Genomics Hum Genet 2009; 10:45-61; PMID:19405848; http://dx.doi.org/10.1146/annurev-genom-082908- 150046.
20. Blackburn EH. Walking the walk from genes through telomere maintenance to cancer risk. Cancer Prev Res (Phila) 2011; 4:473-5; PMID:21460394; http://dx.doi.org/10.1158/1940-6207.CAPR-11-0066.
21. Bessler M, Wilson DB, Mason PJ. Dyskeratosiscongenita. FEBS Lett 2010; 584:3831-8; PMID:20493861; http://dx.doi.org/10.1016/j.febslet.2010.05.019.
22. Gu B, Bessler M, Mason PJ. Dyskerin, telomerase and the DNA damage response. Cell Cycle 2009; 8:6-10; PMID:19106610; http://dx.doi.org/10.4161/cc. 8.1.7265.
23. Mason PJ, Bessler M. The genetics of dyskeratosiscongenita. Cancer Genetics 2011; 204:635-45; PMID:22285015; http://dx.doi.org/10.1016/j.cancergen. 2011.11.002.
24. Savage SA, Bertuch AA. The genetics and clinical manifestations of telomere biology disorders. Genet Med 2010; 12:753-64; PMID:21189492; http://dx.doi.org/10.1097/GIM.0b013e3181f415b5.
25. Walne AJ, Dokal I. DyskeratosisCongenita: a historical perspective. Mech Ageing Dev 2008; 129:48-59; PMID:18054794; http://dx.doi.org/10.1016/j.mad.2007. 10.006.
26. Armanios M. Telomerase and idiopathic pulmonary fibrosis. Mutat Res 2012; 730:52-8; PMID:22079513; http://dx.doi.org/10.1016/j.mrfmmm.2011.10.013.
27. Armanios M, Alder JK, Parry EM, Karim B, Strong MA, Greider CW. Short telomeres are sufficient to cause the degenerative defects associated with aging. Am J Hum Genet 2009; 85:823-32; PMID:19944403; http://dx.doi.org/10.1016/ j.ajhg.2009.10.028.
28. Armanios M, Chen JL, Chang YP, Brodsky RA, Hawkins A, Griffin CA, et al. Haploinsufficiency of telomerase reverse transcriptase leads to anticipation in autosomal dominant dyskeratosiscongenita. Proc Natl Acad Sci USA 2005; 102:15960-4; PMID:16247010; http://dx.doi.org/10.1073/pnas.0508124102.
29. Autexier C, Greider CW. Telomerase and cancer: revisiting the telomere hypothesis. Trends BiochemSci 1996; 21:387-91; PMID:8918193.
30. Greider CW, Blackburn EH. Telomeres, telomerase and cancer. Sci Am 1996; 274:92-7; PMID:8560215; http://dx.doi.org/10.1038/scientificamerican0296-92.
31. Neumann AA, Reddel RR. Telomere maintenance and cancer - look, no telomerase. Nat Rev Cancer 2002; 2:879-84; PMID:12415258; http://dx.doi.org/10. 1038/nrc929.
32. Shay JW, Wright WE. Telomeres and telomerase in normal and cancer stem cells. FEBS Lett 2010; 584:3819-25; PMID:20493857; http://dx.doi.org/10.1016/j. febslet.2010.05.026.
33. Ogrunc M, di Fagagna F. Never-ageing cellular senescence. Eur J Cancer 2011; 47:1616-22; PMID:21561762; http://dx.doi.org/10.1016/j.ejca.2011.04.003.
34. Baur JA, Zou Y, Shay JW, Wright WE. Telomere position effect in human cells. Science 2001; 292:2075-7; PMID:11408657; http://dx.doi.org/10.1126/ science.1062329.
35. Luke B, Lingner J. TERRA: telomeric repeat-containing RNA. EMBO J 2009; 28:2503-10; PMID:19629047; http://dx.doi.org/10.1038/emboj.2009.166.
36. Luke B, Panza A, Redon S, Iglesias N, Li Z, Lingner J. The Rat1p 5′ to 3′ exonuclease degrades telomeric repeat-containing RNA and promotes telomere elongation in Saccharomyces cerevisiae. Mol Cell 2008; 32:465-77; PMID:19026778; http://dx.doi.org/10.1016/j.molcel.2008.10.019.
37. Azzalin CM, Reichenbach P, Khoriauli L, Giulotto E, Lingner J. Telomeric repeat containing RNA and RNA surveillance factors at mammalian chromosome ends. Science 2007; 318:798-801; PMID:17916692; http://dx.doi.org/10.1126/science. 1147182.
38. Porro A, Feuerhahn S, Reichenbach P, Lingner J. Molecular dissection of telomeric repeat-containing RNA biogenesis unveils the presence of distinct and multiple regulatory pathways. Mol Cell Biol 2010; 30:4808-17; PMID:20713443; http://dx.doi.org/10.1128/MCB.00460-10.
39. Deng Z, Norseen J, Wiedmer A, Riethman H, Lieberman PM. TERRA RNA binding to TRF2 facilitates heterochromatin formation and ORC recruitment at telomeres. Mol Cell 2009; 35:403-13; PMID:19716786; http://dx.doi.org/10.1016/j.molcel. 2009.06.025.
40. Azzalin CM, Lingner J. Telomeres: the silence is broken. Cell Cycle 2008; 7:1161-5; PMID:18418035; http://dx.doi.org/10.4161/cc.7.9.5836.
41. Schoeftner S, Blasco MA. Developmentally regulated transcription of mammalian telomeres by DNA-dependent RNA polymerase II. Nat Cell Biol 2008; 10:228-36; PMID:18157120; http://dx.doi.org/10.1038/ncb1685.
42. Sfeir A, Kabir S, van Overbeek M, Celli GB, de Lange T. Loss of Rap1 induces telomere recombination in the absence of NHEJ or a DNA damage signal. Science 2010; 327:1657-61; PMID:20339076; http://dx.doi.org/10.1126/science. 1185100.
43. Redon S, Reichenbach P, Lingner J. Protein RNA and protein protein interactions mediate association of human EST1A/SMG6 with telomerase. Nucleic Acids Res 2007; 35:7011-22; PMID:17940095; http://dx.doi.org/10.1093/nar/gkm724.
44. Chawla R, Redon S, Raftopoulou C, Wischnewski H, Gagos S, Azzalin CM. Human UPF1 interacts with TPP1 and telomerase and sustains telomere leading-strand replication. EMBO J 2011; 30:4047-58; PMID:21829167; http://dx.doi.org/10.1038/emboj.2011.280.
45. Feuerhahn S, Iglesias N, Panza A, Porro A, Lingner J. TERRA biogenesis, turnover and implications for function. FEBS Lett 2010; 584:3812-8; PMID:20655916; http://dx.doi.org/10.1016/j.febslet.2010.07.032.
46. Flynn RL, Centore RC, O'Sullivan RJ, Rai R, Tse A, Songyang Z, et al. TERRA and hnRNPA1 orchestrate an RPA-to-POT1 switch on telomeric single-stranded DNA. Nature 2011; 471:532-6; PMID:21399625; http://dx.doi.org/10.1038/ nature09772.
47. Chawla R, Azzalin CM. The telomerictranscriptome and SMG proteins at the crossroads. Cytogenet Genome Res 2008; 122:194-201; PMID:19188687; http://dx.doi.org/10.1159/000167804.
48. Farnung BO, Giulotto E, Azzalin CM. Promoting transcription of chromosome ends. Transcription 2010; 1:140-3; PMID:21326888; http://dx.doi.org/10.4161/ trns.1.3.13191.
49. Iglesias N, Redon S, Pfeiffer V, Dees M, Lingner J, Luke B. Subtelomeric repetitive elements determine TERRA regulation by Rap1/Rif and Rap1/Sir complexes in yeast. EMBO Rep 2011; 12:587-93; PMID:21525956; http://dx.doi.org/10.1038/embor.2011.73.
50. Nergadze SG, Farnung BO, Wischnewski H, Khoriauli L, Vitelli V, Chawla R, et al. CpG-island promoters drive transcription of human telomeres. RNA 2009; 15:2186-94; PMID:19850908; http://dx.doi.org/10.1261/rna.1748309.
51. Cao F, Li X, Hiew S, Brady H, Liu Y, Dou Y. Dicer independent small RNAs associate with telomeric heterochromatin. RNA 2009; 15:1274-81; PMID:19460867; http://dx.doi.org/10.1261/rna.1423309.
52. Sandell LL, Gottschling DE, Zakian VA. Transcription of a yeast telomere alleviates telomere position effect without affecting chromosome stability. Proc Natl Acad Sci USA 1994; 91:12061-5; PMID:7991584; http://dx.doi.org/10.1073/ pnas.91.25.12061.
53. Redon S, Reichenbach P, Lingner J. The non-coding RNA TERRA is a natural ligand and direct inhibitor of human telomerase. Nucleic Acids Res 2010; 38:5797-806; PMID:20460456; http://dx.doi.org/10.1093/nar/gkq296.
54. Farnung BO, Brun CM, Arora R, Lorenzi LE, Azzalin CM. Telomerase efficiently elongates highly transcribing telomeres in human cancer cells. PLoS ONE 2012; In press.
55. Arora R, Brun CM, Azzalin CM. Transcription regulates telomere dynamics in human cancer cells. RNA 2012; 18:684-93; PMID:22357912; http://dx.doi.org/10. 1261/rna.029587.111.
56. Maicher A, Kastner L, Dees M, Luke B. Telomere transcription casuses replication dependent telomere shortening and promotes cellular senescence. Nucleic Acids Res 2012; In press.
57. Poveda AM, Le Clech M, Pasero P. Transcription and replication: breaking the rules of the road causes genomic instability. Transcription 2010; 1:99-102; PMID:21326900; http://dx.doi.org/10.4161/trns.1.2.12665.
58. Gómez-González B, García-Rubio M, Bermejo R, Gaillard H, Shirahige K, Marín A, et al. Genome-wide function of THO/TREX in active genes prevents R-loop-dependent replication obstacles. EMBO J 2011; 30:3106-19; PMID:21701562; http://dx.doi.org/10.1038/emboj.2011.206.
59. Aguilera A, Gómez-González B. Genome instability: a mechanistic view of its causes and consequences. Nat Rev Genet 2008; 9:204-17; PMID:18227811; http://dx.doi.org/10.1038/nrg2268.
60. Chawla R, Redon S, Raftopoulou C, Wischnewski H, Gagos S, Azzalin CM. Human UPF1 interacts with TPP1 and telomerase and sustains telomere leading-strand replication. EMBO J 2011; 30:4047-58; PMID:21829167; http://dx.doi.org/10.1038/emboj.2011.280.
61. de Bruin D, Kantrow SM, Liberatore RA, Zakian VA. Telomere folding is required for the stable maintenance of telomere position effects in yeast. Mol Cell Biol 2000; 20:7991-8000; PMID:11027269; http://dx.doi.org/10.1128/MCB.20. 21.7991-8000.2000.
62. Vodenicharov MD, Laterreur N, Wellinger RJ. Telomere capping in non-dividing yeast cells requires Yku and Rap1. EMBO J 2010; 29:3007-19; PMID:20628356; http://dx.doi.org/10.1038/emboj.2010.155.
63. Chang M, Dittmar JC, Rothstein R. Long telomeres are preferentially extended during recombination-mediated telomere maintenance. Nat Struct Mol Biol 2011; 18:451-6; PMID:21441915; http://dx.doi.org/10.1038/nsmb.2034.
64. Ehrlich M. The ICF syndrome, a DNA methyltransferase 3B deficiency and immunodeficiency disease. Clin Immunol 2003; 109:17-28; PMID:14585272; http://dx.doi.org/10.1016/S1521-6616(03)00201-8.
65. Yehezkel S, Segev Y, Viegas-Péquignot E, Skorecki K, Selig S. Hypomethylation of subtelomeric regions in ICF syndrome is associated with abnormally short telomeres and enhanced transcription from telomeric regions. Hum Mol Genet 2008; 17:2776-89; PMID:18558631; http://dx.doi.org/10.1093/hmg/ ddn177.
66. Alcaín FJ, Villalba JM. Sirtuin activators. Expert Opin Ther Pat 2009; 19:403-14; PMID:19441923; http://dx.doi.org/10.1517/13543770902762893.
67. Chen J, Zhang B, Wong N, Lo AW, To KF, Chan AW, et al. Sirtuin 1 is upregulated in a subset of hepatocellular carcinomas where it is essential for telomere maintenance and tumor cell growth. Cancer Res 2011; 71:4138-49; PMID:21527554; http://dx.doi.org/10.1158/0008-5472.CAN-10-4274.
68. Palacios JA, Herranz D, De Bonis ML, Velasco S, Serrano M, Blasco MA. SIRT1 contributes to telomere maintenance and augments global homologous recombination. J Cell Biol 2010; 191:1299-313; PMID:21187328; http://dx.doi.org/10.1083/jcb.201005160.
69. Michishita E, McCord RA, Berber E, Kioi M, Padilla-Nash H, Damian M, et al. SIRT6 is a histone H3 lysine 9 deacetylase that modulates telomeric chromatin. Nature 2008; 452:492-6; PMID:18337721; http://dx.doi.org/10.1038/ nature06736.
70. Ng LJ, Cropley JE, Pickett HA, Reddel RR, Suter CM. Telomerase activity is associated with an increase in DNA methylation at the proximal subtelomere and a reduction in telomeric transcription. Nucleic Acids Res 2009; 37:1152-9; PMID:19129228; http://dx.doi.org/10.1093/nar/gkn1030.
71. Harley CB. Telomerase and cancer therapeutics. Nat Rev Cancer 2008; 8:167-79; PMID:18256617; http://dx.doi.org/10.1038/nrc2275.
72. Shay JW, Wright WE. Telomeres and telomerase in normal and cancer stem cells. FEBS Lett 2010; 584:3819-25; PMID:20493857; http://dx.doi.org/10.1016/j. febslet.2010.05.026.